Vitas Pharma

Indian, preclinical stage biopharma developing small molecule therapeutics for MDR bacterial infections (ESKAPE pathogens)

placeHyderabad, Telangana, India calendar_todayFounded 2010 groups6 employees language vitaspharma.com

Registered entities

Innovation

4 patent families (2 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 72 times.

YearFilings
20131
20142
20152
20161
20172
20182
20211
20221

Investor mix

47 investors on record; lead investors include Array.

Investor typeCountShare
Venture capital12%
Angel & family office24%
Accelerator & incubator24%
Bank & private debt12%
Other / undisclosed4187%
Coming soon